Dementia and Alzheimer Disease

Epilepsy

Migraine

Headache and Migraine

MS Advanced Practice Providers

Multiple Sclerosis

NMOSD

MS and Demyelinating Disorders

Parkinson Disease

Movement Disorders

Ataxia

Chronic Inflammatory Demyelinating Polyneuropathy

Muscular Dystrophy

Neuromuscular

Insomnia

Narcolepsy

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

Special Report

NeurologyLive Peer Exchange

Medcast

Peers & Perspectives

Roundtable Discussions

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

Bridging the Gaps

International Journal of MS Care

Resources

Expert Authors

FDA News

Features

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

Articles

A new meta-analysis revealed that the efficacy of MRI-guided focused ultrasound decreased over time in essential tremor, with sensory symptoms and unsteadiness as common adverse effects.

MRI-Guided Focused Ultrasound Demonstrates Efficacy for Essential Tremor, But Effect Decreases Over Time

Videos

The division chief of neurology at Nemours Children’s Hospital discussed evolving surgical techniques, neuromodulation therapies, and precision medicine approaches for complex epilepsy cases. [WATCH TIME: 5 minutes]

Advances in Surgical and Neuromodulation Strategies for Epilepsy Management: Satyanarayana Gedela, MD

A recently published meta-analysis reported that fatty acid supplementation, particularly omega-3, may significantly reduce severity, duration, and frequency of migraine in patients.

Meta-Analysis Reveals Fatty Acid Supplementation Linked to Migraine Symptom Improvement

Pooled analysis from KINECT-3 and KINECT-4 confirms valbenazine’s long-term safety and efficacy in managing tardive dyskinesia in elderly patients.

Valbenazine Safe and Effective for Long-Term Treatment of Tardive Dyskinesia in Elders

, has been with the team since September 2022. Follow her on Twitter 

Bruce Bebo, PhD, and Amit Bar-Or, MD, FRCPC, FAAN, FANA, discussed the impact of the John Dystel Prize on multiple sclerosis research and its role in shaping future clinical advancements. 

Advancing MS Research Through Recognition and Innovation: The John Dystel Prize

Founder and Executive Director, Sumaira Foundation

The founder and executive director of the Sumaira Foundation emphasized the critical role of lifestyle factors such as sleep, exercise, and nutrition for maintaining brain health in patients with NMOSD. [WATCH TIME: 3 minutes]

Prioritizing Brain Health in NMOSD Beyond Disease-Modifying Therapies: Sumaira Ahmed

Division Chief of Neurology, Dayton Children's Hospital

The division chief of child neurology at Dayton Children’s Hospital discussed findings from a study comparing patient satisfaction scores between telehealth and in-person visits in pediatric epilepsy care. [WATCH TIME: 4 minutes]

Comparable Evidence of Telehealth Benefits vs In-Person Care for Pediatrics: Gogi Kumar, MD

Interim chief executive officer of the Consortium of Multiple Sclerosis Centers.

IJMSC Insights offers a closer look at the latest research and the people behind it from the community of the International Journal of Multiple Sclerosis Care (IJMSC) and the Consortium of Multiple Sclerosis Centers (CMSC).

IJMSC Insights: Kathleen Costello, Interim CEO of CMSC

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

LinkedIN

YouTube

Spotlight

AAN 2025

AD/PD 2025

MDA 2025

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

News Network

 Peer Exchange video series features panels of expert physicians engaging in in-depth discussions about practice-changing treatments, challenges in care, and the future paradigm of management for neurologic diseases.

Peer Exchange

1rem

Expert panelists review insomnia diagnosis and clinical manifestations, non-pharmacological management, pharmacological treatment options, and new agents on the horizon.

Unmet Needs in Treating Insomnia

Expert neurologists provide a discussion on current treatment options for migraine and review data from recent clinical trials.

The Changing Landscape of Preventive Treatment of Migraine

Experts discuss the causes, impact on quality of life, and the management of morning OFF episodes in Parkinson’s disease.

Parkinson’s Disease On-Demand Morning Therapy

Recommendations for selecting and sequencing therapies used to treat patients with relapsing multiple sclerosis.

Optimal Management of Relapsing Multiple Sclerosis:  Advanced Practice Providers Perspectives

Fred D. Lublin, MD; Ravi Dukkipati, MD; Gavin Giovannoni, MD; and Lauren Gluck, MD explore several topics pertaining to the diagnosis and treatment of relapsing multiple sclerosis (MS), including current treatment options, therapy sequencing, and the future of MS management.

Optimal Management of Relapsing Multiple Sclerosis 

Neurology experts discuss the diagnosis and treatment of advanced Parkinson disease.

Recognizing and Managing Advanced Parkinson Disease 

Panelists discuss recommendations for the diagnosis, treatment, and management of patients with Dravet Syndrome.

Redefining Treatment Outcomes in Dravet Syndrome

Recommendations for appropriate treatment selection and use of high efficacy therapies as treatment for relapsing-remitting multiple sclerosis.

Strategies in Treating Relapsing-Remitting Multiple Sclerosis

Crystal Proud, MD; Claudia Chiriboga, MD, MPH; Tom Crawford, MD; Basil Darras, MD; and Carolina Tesi Rocha, MD provide a discussion on the importance of early diagnosis and treatment of spinal muscular atrophy and consider data from recent clinical trials of disease-modifying therapy options. 

The Changing Landscape in the Treatment of Spinal Muscular Atrophy

Richard S. Bedlack, MD, PhD, MS; Ammar Al-Chalabi, MB, ChB, PhD; Jinsy A. Andrews, MD, MSc; and Jeremy M. Schefner, MD, PhD discuss the current treatment landscape for amyotrophic lateral sclerosis (ALS) and provide insights into ongoing clinical trials and recent results. 

Progress in the Treatment of Amyotrophic Lateral Sclerosis (ALS) 

Experts discuss the diagnosis and treatment of progressive multiple sclerosis.

Management of Progressive Multiple Sclerosis

Key insight into treating ATTR Amyloidosis, including the use of new therapeutic options to provide a practical perspective on how recent data may apply to your clinical practice. 

Recent Advances in the Treatment of Hereditary ATTR Amyloidosis (hATTR)  

Fred Lublin, MD; Patricia K. Coyle, MD; Mark Freedman, MD; and Scott D. Newsome, DO, discuss a number of topics pertaining to the diagnosis of multiple sclerosis, including a focus on fatigue and its impact on quality of life.

Updates in the Management of Relapsing Multiple Sclerosis

Advances in the Management of Acute Treatment of Migraine

Global Approaches to the Management of Relapsing Multiple Sclerosis

Management of Cardiac Amyloidosis 

Advances in the Treatment of Spinal Muscular Atrophy

Management of Narcolepsy and Excessive Daytime Sleepiness

Updates to the MRI Protocol and Clinical Guidelines for MS: CMSC Working Group

Advances in Early Treatment Approaches in Multiple Sclerosis

Managing OFF Episodes in Parkinson Disease

Advances in the Treatment of Alzheimer

Treatment of Multiple Sclerosis Relapses

New Paradigms: Preventive Treatment for Chronic Migraine 

Dravet Syndrome and Lennox-Gastaut Syndrome: Recent Treatment Advances

Understanding Spinal Muscular Atrophy (SMA) and the Recent Advances in Management

Understanding Hereditary ATTR (hATTR) Amyloidosis and the Recent Advances in Management

Advances in the Diagnosis and Management of Multiple Sclerosis

Epilepsy: Current Trends and Treatments for Focal Seizures